Facebook
Twitter
Telegram
Report an ErrorGT Biopharma Balance Sheet 2011-2024 | GTBP
Annual Balance Sheet GT Biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-5.5 M | - | 21 K | 13.3 M | 10.7 M | -545 K | 12.4 M | 8.53 M | 1.53 M | 1.67 M | 1.76 M | 1.97 M | |
Long Term Debt |
- | 64 K | - | - | - | - | - | - | 714 K | 634 K | 97 K | - | - |
Long Term Debt Current |
58 K | 110 K | - | - | 120 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | 714 K | 634 K | 97 K | - | - |
Total Current Liabilities |
6.63 M | 4.94 M | 10.3 M | 35.1 M | 19.7 M | 14 M | 2.68 M | 18.9 M | 49.9 M | 29.8 M | 6.38 M | 6.56 M | 5.23 M |
Total Liabilities |
6.63 M | 5 M | 10.3 M | 5.66 K | 19.7 M | 14 M | 2.68 M | 18.9 M | 61.9 M | 30.5 M | 6.48 M | 6.56 M | 5.23 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-682 M | -674 M | -654 M | - | -567 M | -529 M | -268 M | -125 M | -146 M | -113 M | -89.5 M | -89 M | -83.8 M |
Total Assets |
14.1 M | 16.7 M | 32.2 M | 5.66 K | 396 K | 25.4 M | 254 M | 25 K | 54 K | 888 K | 147 K | 226 K | 129 K |
Cash and Cash Equivalents |
1.08 M | 5.67 M | 8.97 M | 5.3 M | 28 K | 60 K | 576 K | 19 K | 47 K | 855 K | 43 K | 123 K | 92 K |
Book Value |
7.48 M | 11.7 M | 21.9 M | - | -19.3 M | 11.4 M | 252 M | -18.9 M | -61.8 M | -29.6 M | -6.33 M | -6.34 M | -5.1 M |
Total Shareholders Equity |
7.48 M | 11.7 M | 21.9 M | -29.4 M | -19.3 M | 11.4 M | 252 M | -18.9 M | -50.6 M | -29.6 M | -6.33 M | -6.34 M | -5.1 M |
All numbers in USD currency
Quarterly Balance Sheet GT Biopharma
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 31 K | 64 K | 92 K | 120 K | 147 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 400 K | 528 K | 553 K | 714 K | 714 K | 714 K | 714 K | 634 K | 634 K | 634 K | 634 K | 97 K | 97 K | 97 K | 97 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 400 K | 528 K | 553 K | 714 K | 714 K | 714 K | 714 K | 634 K | 634 K | 634 K | 634 K | 97 K | 97 K | 97 K | 97 K | - | - | - | - | - | - | - | - |
Total Liabilities |
4.6 M | 6.63 M | 6.14 M | 6.38 M | 7.03 M | 5 M | 5.12 M | 8.73 M | 9.65 M | 10.3 M | - | - | - | - | 30.7 M | - | 21.2 M | 19.7 M | 18.8 M | 16.7 M | 19.7 M | 14 M | 14 M | 14 M | 14 M | 2.68 M | 2.68 M | 2.68 M | 2.68 M | 18.9 M | 18.9 M | 16.2 M | 18.9 M | 50.6 M | 50.6 M | 50.6 M | 50.6 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 6.48 M | 6.48 M | 6.48 M | 6.48 M | 6.56 M | - | - | - | 5.23 M | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-684 M | -682 M | -679 M | -677 M | -675 M | -674 M | -669 M | -662 M | -659 M | -654 M | -635 M | -630 M | -625 M | -596 M | -596 M | -596 M | -596 M | -567 M | -567 M | -567 M | -567 M | -529 M | -529 M | -529 M | -529 M | -269 M | -269 M | -269 M | -269 M | -125 M | -125 M | -125 M | -125 M | -134 M | -134 M | -134 M | -134 M | -113 M | -113 M | -113 M | -113 M | -89.5 M | -89.5 M | -89.5 M | -89.5 M | -89 M | -89 M | -89 M | -89 M | -83.8 M | -83.8 M | -83.8 M | -83.8 M |
Total Assets |
9.91 M | 14.1 M | 16.1 M | 18.1 M | 20.1 M | 16.7 M | 21.1 M | 24.2 M | 27.4 M | 32.2 M | - | - | - | 5.66 M | 917 K | 1.06 M | 295 K | 396 K | 396 K | 396 K | 396 K | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 254 M | 254 M | 254 M | 254 M | 25 K | 25 K | 25 K | 25 K | 54 K | 54 K | 54 K | 54 K | 888 K | 888 K | 888 K | 888 K | 147 K | 147 K | 147 K | 147 K | 226 K | 226 K | 226 K | 226 K | 129 K | 129 K | 129 K | 129 K |
Cash and Cash Equivalents |
1.95 M | 1.08 M | 2.65 M | 2.77 M | 2.04 M | 5.67 M | 2.46 M | 5.36 M | 7.29 M | 8.97 M | 9.68 M | 39.5 M | 27.6 M | 5.3 M | 350 K | 851 K | 5 K | 28 K | 28 K | 28 K | 28 K | 60 K | 60 K | 60 K | 60 K | 576 K | 576 K | 576 K | 576 K | 19 K | 19 K | 19 K | 19 K | 47 K | 47 K | 47 K | 47 K | 855 K | 855 K | 855 K | 855 K | 43 K | 43 K | 43 K | 43 K | 123 K | 123 K | 123 K | 123 K | 92 K | 92 K | 92 K | 92 K |
Book Value |
5.31 M | 7.48 M | 10 M | 11.8 M | 13.1 M | 11.7 M | 16 M | 15.4 M | 17.8 M | 21.9 M | - | - | - | 5.66 M | -29.8 M | 1.06 M | -20.9 M | -19.3 M | -18.4 M | -16.3 M | -19.3 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 252 M | 252 M | 252 M | 252 M | -18.9 M | -18.9 M | -16.2 M | -18.9 M | -50.6 M | -50.6 M | -50.6 M | -50.6 M | -29.6 M | -29.6 M | -29.6 M | -29.6 M | -6.33 M | -6.33 M | -6.33 M | -6.33 M | -6.34 M | 226 K | 226 K | 226 K | -5.1 M | 129 K | 129 K | 129 K |
Total Shareholders Equity |
5.31 M | 7.48 M | 10 M | 11.8 M | 13.1 M | 11.7 M | 16 M | 15.4 M | 17.8 M | 21.9 M | 31.9 M | 36.3 M | 24 M | -29.4 M | -29.4 M | -29.4 M | -29.4 M | -19.3 M | -19.3 M | -19.3 M | -19.3 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 252 M | 252 M | 252 M | 252 M | -18.9 M | -18.9 M | -18.9 M | -18.9 M | -50.6 M | -50.6 M | -50.6 M | -50.6 M | -29.6 M | -29.6 M | -29.6 M | -29.6 M | -6.33 M | -6.33 M | -6.33 M | -6.33 M | -6.34 M | -6.34 M | -6.34 M | -6.34 M | -5.1 M | -5.1 M | -5.1 M | -5.1 M |
All numbers in USD currency